These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 6316668

  • 1. [Clinical use of new cephalosporins for severe infections in internal medicine].
    Stille W.
    Wien Klin Wochenschr Suppl; 1983; 142():18-20. PubMed ID: 6316668
    [Abstract] [Full Text] [Related]

  • 2. [In-vitro activity of cefotaxime].
    Knothe H.
    Wien Klin Wochenschr Suppl; 1983; 142():4-7. PubMed ID: 6316671
    [Abstract] [Full Text] [Related]

  • 3. [Preventive and therapeutic application possibilities of newer antibiotics (author's transl)].
    Marget W.
    MMW Munch Med Wochenschr; 1979 Sep 07; 121(36):1133-6. PubMed ID: 114782
    [Abstract] [Full Text] [Related]

  • 4. Nosocomial pneumonia.
    Preheim LC, Sanders WE.
    Compr Ther; 1981 Jun 07; 7(6):20-7. PubMed ID: 7018827
    [No Abstract] [Full Text] [Related]

  • 5. [Cefotaxime in digestive tract infections (author's transl)].
    Paris J, Paris JC, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):647-9. PubMed ID: 6259611
    [Abstract] [Full Text] [Related]

  • 6. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
    Ko WC, Lee HC, Chuang YC, Liu CC, Wu JJ.
    J Infect; 2000 May 26; 40(3):267-73. PubMed ID: 10908022
    [Abstract] [Full Text] [Related]

  • 7. Gentamicin therapy administered by intermittent intravenous injections.
    Korner B.
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 May 26; ():Suppl 241:15-2. PubMed ID: 4521603
    [No Abstract] [Full Text] [Related]

  • 8. Recent advances in chemotherapy.
    Murdoch JM, Geddes AM, Munro JF.
    S Afr Med J; 1968 Jan 20; 42(3):54-7. PubMed ID: 5638047
    [No Abstract] [Full Text] [Related]

  • 9. The newer antibiotics: some therapeutic considerations.
    Bullock WE.
    J Ky Med Assoc; 1972 Feb 20; 70(2):109-13. PubMed ID: 5016961
    [No Abstract] [Full Text] [Related]

  • 10. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW.
    Clin Infect Dis; 2004 Sep 15; 39(6):812-8. PubMed ID: 15472813
    [Abstract] [Full Text] [Related]

  • 11. The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
    Wilson WR, Bouza E, Lode H, Mouton Y.
    J Chemother; 1997 May 15; 9 Suppl 2():5-18. PubMed ID: 9248972
    [Abstract] [Full Text] [Related]

  • 12. [In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa].
    Modde H.
    Schweiz Med Wochenschr; 1981 Mar 07; 111(10):356-8. PubMed ID: 6452690
    [Abstract] [Full Text] [Related]

  • 13. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB, Canton P, Roche G, Weber M, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):601-6. PubMed ID: 6259602
    [Abstract] [Full Text] [Related]

  • 14. Basic design of beta-lactam antibiotics--cephalosporins.
    Price KE, McGregor DN.
    Scand J Infect Dis Suppl; 1984 Feb 26; 42():50-63. PubMed ID: 6597562
    [Abstract] [Full Text] [Related]

  • 15. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Feb 26; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 16. Third-generation cephalosporins: a critical evaluation.
    Barriere SL, Flaherty JF.
    Clin Pharm; 1984 Feb 26; 3(4):351-73. PubMed ID: 6432420
    [Abstract] [Full Text] [Related]

  • 17. Carbenicillin plus cephalothin or cefazolin as therapy for infections in neutropenic patients.
    Bodey GP, Valdivieso M, Feld R, Rodriguez V, McCredie K.
    Am J Med Sci; 1977 Feb 26; 273(3):309-18. PubMed ID: 326048
    [No Abstract] [Full Text] [Related]

  • 18. [Nosocomial bacteria: profiles of resistance].
    Sow AI.
    Dakar Med; 2005 Feb 26; 50(1):7-9. PubMed ID: 16190117
    [Abstract] [Full Text] [Related]

  • 19. Treatment with gentamicin. Application and therapeutic effect.
    Belfrage S, Banck G, Nordström L.
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Feb 26; ():Suppl 241:62-4. PubMed ID: 4521608
    [No Abstract] [Full Text] [Related]

  • 20. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J, Sauvaget J.
    Nouv Presse Med; 1981 Feb 26; 10(8):650-3. PubMed ID: 6259612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.